June 1st, 2021 – Rescue Hearing Inc. (RHI) has reached an exciting milestone in the fight against genetic hearing loss. Our latest research has unveiled a novel gene therapy technique designed to restore hearing in individuals affected by STRC gene mutations, a common cause of hereditary hearing impairment.

This breakthrough therapy works by replacing defective genes with functional ones, effectively restoring inner ear hair cell function. Early preclinical trials have shown promising results, with treated subjects experiencing significant improvements in auditory function.

“For too long, individuals with genetic hearing loss have had limited options. Our breakthrough paves the way for a potential cure, not just a temporary solution,” said Jim Ayala, CEO of RHI. “We are excited to move this research forward into clinical trials and bring hope to millions.”

RHI is now preparing for the next phase of development, including regulatory approvals and patient recruitment for upcoming clinical trials.